Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

A woman was allergic to quinine in her anti-hair loss lotion.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Transplant patients often get skin problems, with treatments varying by condition.

A newborn with ichthyosis was successfully treated using specific neonatal care methods.

Expand access to prevention and address barriers for sex workers in Kostanay.

Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Certain drugs that block specific enzymes can help treat prostate diseases.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.